跳至主要内容
临床试验/NCT07233109
NCT07233109尚未招募不适用

Energy Expenditure and Neuromuscular Function in Young Adult Women With a Naturally Thin Build (LeanErgy)

Centre Hospitalier Emile Roux1 个研究点 分布在 1 个国家目标入组 36 人开始时间: 2025年12月15日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
36
试验地点
1
主要终点
Energy cost

研究概览

简要总结

People with a low BMI (<17.5) are most often considered to have anorexia nervosa (AN). However, recent literature suggests that there is a category of individuals with the same low BMI who do not meet the diagnostic criteria for anorexia nervosa but who have specific differences that make them a separate entity: constitutional thinness (CM). Constitutional thinness differs from anorexia nervosa in several ways. First, unlike AN, CM individuals do not have eating disorders and express a strong desire to gain weight. Another difference concerns the menstrual cycle: without oral contraception, AN individuals experience amenorrhea, while CM individuals have regular menstrual cycles. Biological signs of malnutrition are also present in anorexia nervosa, whereas this is not the case in constitutional thinness. Indeed, concentrations of IGF1, free T3, and leptin are significantly reduced in AN compared to healthy subjects, whereas there is no significant difference between healthy subjects and CT. Finally, in terms of body composition, there is a significant difference in particular in the percentage of fat mass between MC and AM subjects, with the MC group having a significantly lower percentage of fat mass than the control subjects but significantly higher than the AM subjects. The clinical management of MC patients could involve nutritional management of patients but also management in the form of an Adapted Physical Activity intervention program. However, this type of program using physical activity and a nutritional approach must be based on a characterization of the energy profile and physical abilities of MC patients, which remains to be studied. Germain et al. proposed measuring the physical activity level of MC patients using Actiheart (a combination of heart rate and accelerometer) and compared it with that of normal-weight (NW) individuals, finding no difference between the groups. However, this analysis remains a secondary analysis of their study, as the statistical power and choice of tool are certainly not appropriate for this question. Our team recently conducted the Nutrilean project, which for the first time questioned the aerobic and muscular capacities of women with CM compared to their NP counterparts. While our results show lower force production capacity in CM patients, suggesting neuromuscular adaptations to the chronic mechanical unloading caused by CM rather than an impairment of contractile abilities themselves, this remains to be explored more specifically. Indeed, these differences disappeared after normalization to body weight or muscle mass, suggesting a reduced gross force production capacity, but probably reflecting a normal physiological adaptation to low body and muscle mass. It now appears necessary to carry out more specific neuromuscular analyses in order to better understand the mechanisms, adaptations, and/or potential neuromuscular dysfunctions in this population. Similarly, while the results do not appear to show any impairment in the aerobic capacity of CM, they do highlight a potential impairment in their energy efficiency during locomotion, which may also reflect an adaptation to chronic exposure to lower mechanical loads.

In this context and following on from the work carried out to date by our team, the main objective of this study is i) to compare the lipid oxidation capacity and energy cost of walking between MC and NP participants; ii) to explore the adaptations of this energy cost in MC women in response to mechanical overload.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Other
盲法
None

入排标准

年龄范围
18 Years 至 35 Years(Adult)
性别
Female
接受健康志愿者
否

入选标准

  • •BMI ≤ 17.5 kg/m2
  • •20 kg/m2 ≤ BMI ≤ 25 kg/m2

排除标准

  • •For women with Constitutional thinness :
  • •Women under guardianship or deprived of their liberty by judicial or administrative decision
  • •Women who are pregnant, breastfeeding, or likely to become pregnant
  • •Women who engage in intense physical activity (more than 3 sessions of physical activity per week)
  • •Abnormal levels of IGF-1, estradiol, free T3, cortisol, and leptin
  • •For the MC group specifically: cases of thinness due to a suspected organic cause. This includes Marfan syndrome, identifiable by: personal or family history of degenerative aortic disease (aneurysm, dissection), ligamentous hyperlaxity, arachnodactyly
  • •History or presence of a systemic condition likely to interfere with the physiological and metabolic parameters measured (e.g., diabetes, endocrine or metabolic disease)
  • •Any acute or chronic disease that may influence the results (e.g., infections, tumors, inflammatory diseases)
  • •Medical or surgical history deemed by the investigator to be incompatible with this study (e.g., muscular, neurological, or joint disorders, or contraindications to the application of a magnetic field, etc.) Presence of diabetes, and any other condition limiting the application of either strategy under trial
  • •Use of medications that may interfere with the study results
  • •Cardiovascular conditions (history of cardiovascular and/or neurovascular disease, as well as the presence of cardiovascular and/or neurovascular risk factors other than obesity/overweight, such as: high blood pressure, high cholesterol, diabetes, heart rhythm disorder, known carotid atherosclerosis, thrombophilia)
  • •Surgery within the previous 3 months
  • •Women excluded from another study
  • •Regular tobacco or alcohol consumption
  • •Specific diets likely to impact metabolism, influence biological parameters (FT3, cortisol in particular) or skew results (deficiencies, low calorie intake). This includes vegan, mono, ketogenic, and low-calorie diets, intermittent fasting, or diets requiring specific supplementation that may interfere with the endocrine system.
  • •For women Normal-Weighted Women
  • •Women under guardianship or deprived of their liberty by judicial or administrative decision
  • •Women who are pregnant, breastfeeding, or likely to become pregnant.
  • •Women who engage in intense physical activity (more than 3 sessions of physical activity per week)
  • •History or presence of a systemic condition likely to interfere with the physiological and metabolic parameters measured (e.g., diabetes, endocrine or metabolic disorders)
  • •Any acute or chronic disease that may influence the results (e.g., infections, tumors, inflammatory diseases)
  • •Medical or surgical history deemed by the investigator to be incompatible with this study (e.g., muscular, neurological, or joint disorders, or contraindications to the application of a magnetic field, etc.)
  • •Presence of diabetes or any other condition limiting the application of either strategy under investigation
  • •Taking medications that may interfere with the study results
  • •Cardiovascular conditions (history of cardiovascular and/or neurovascular disease, as well as the presence of cardiovascular and/or neurovascular risk factors other than obesity/overweight, such as: high blood pressure, high cholesterol, diabetes, heart rhythm disorder, known carotid atherosclerosis, thrombophilia)
  • •Surgery within the previous 3 months
  • •Women excluded from another study
  • •Regular tobacco or alcohol consumption
  • •Specific diets likely to impact metabolism, influence biological parameters, or skew results (deficiencies, low calorie intake). This includes vegan, mono, ketogenic, and low-calorie diets, intermittent fasting, or diets requiring specific supplementation that may interfere with the endocrine system.

研究组 & 干预措施

Woman with constitutional thinness

Experimental

Women aged between 18 and 35 Signed consent form Member of or entitled to social security Body Mass Index ≤ 17.5 kg/m2 Stable weight (no variation of more than 2kg over the last 12 months) No eating disorders No signs of malnutrition according to blood tests for cortisol* and FT3* No secondary amenorrhea

干预措施: Evaluation of the maximum oxidation point of lipids (Diagnostic Test)

Woman with constitutional thinness

Experimental

Women aged between 18 and 35 Signed consent form Member of or entitled to social security Body Mass Index ≤ 17.5 kg/m2 Stable weight (no variation of more than 2kg over the last 12 months) No eating disorders No signs of malnutrition according to blood tests for cortisol* and FT3* No secondary amenorrhea

干预措施: Evaluation of the energy cost of walking (Diagnostic Test)

Woman with constitutional thinness

Experimental

Women aged between 18 and 35 Signed consent form Member of or entitled to social security Body Mass Index ≤ 17.5 kg/m2 Stable weight (no variation of more than 2kg over the last 12 months) No eating disorders No signs of malnutrition according to blood tests for cortisol* and FT3* No secondary amenorrhea

干预措施: Neuro-muscular assessments (Diagnostic Test)

Normal-weight women

Experimental

Women aged between 18 and 35 Signed consent form Member of or entitled to social security Body Mass Index between 20 kg/m² and 25 kg/m² Stable weight (No variation of more than 2 kg over the last 12 months) No eating disorders No secondary amenorrhea

干预措施: Evaluation of the maximum oxidation point of lipids (Diagnostic Test)

Normal-weight women

Experimental

Women aged between 18 and 35 Signed consent form Member of or entitled to social security Body Mass Index between 20 kg/m² and 25 kg/m² Stable weight (No variation of more than 2 kg over the last 12 months) No eating disorders No secondary amenorrhea

干预措施: Evaluation of the energy cost of walking (Diagnostic Test)

Normal-weight women

Experimental

Women aged between 18 and 35 Signed consent form Member of or entitled to social security Body Mass Index between 20 kg/m² and 25 kg/m² Stable weight (No variation of more than 2 kg over the last 12 months) No eating disorders No secondary amenorrhea

干预措施: Neuro-muscular assessments (Diagnostic Test)

结局指标

主要结局

Energy cost

时间窗: 4 months

Indirect calorimetry (measurement of gas exchange)

次要结局

  • Isometric and dynamic strength(4 months)
  • Perception of effort(4 months)
  • Maximum lipid oxidation point(4 months)

研究者

发起方
Centre Hospitalier Emile Roux
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验